High UDG and BRCA1 expression is associated with adverse outcome in patients with pemetrexed treated non-small cell lung Cancer Article

cited authors

  • Sadraei, Nooshin Hashemi; Feng, Yan; Du, Lingling; Fu, Pingfu; Haque, Sulsal; Dowlati, Afshin; Gollamudi, Jahnavi; Pennell, Nathan A.; Mekhail, Tarek; Avril, Stefanie; Farver, Carol; Gerson, Stanton L.; Sharma, Neelesh

authors

Publication Date

  • December 1, 2018

webpage

published in

category

keywords

  • BRCA1
  • Non-small cell lung cancer
  • Pemetrexed
  • UDG
  • Uracil DNA glycosylase

start page

  • 48

end page

  • 54

volume

  • 126